Content Related to Penny Hallett

Video: Lecture – Autologous iPSC-Based Cell Therapy for Parkinson’s Disease

Presented by Penny Hallett, PhD, McLean Hospital – McLean Forum lecture Parkinson’s disease (PD), is characterized by tremor, bradykinesia (slowness of movement), rigidity, and postural instability. At the time of diagnosis, about 60% of the midbrain dopamine (mDA) neurons have already degenerated...

McLean Hospital Receives Coveted NIH Grant to Clinically Study Autologous Stem Cell Therapy for Parkinson’s Disease

The National Institutes of Health (NIH) has awarded McLean Hospital’s Neuroregeneration Institute (NRI) a $6 million grant over 5 years to further its groundbreaking research on stem cell-based therapy for Parkinson’s disease (PD). The NIH developed the Cooperative Research to Enable and Advance...

In the Media: Elevated Lipid Levels May Be Early Biomarker for Parkinson’s, Study Suggests

Drs. Ole Isacson and Penny Hallett find a likely early indicator for Parkinson’s disease.

In the Media: Researchers Find that Lipid Accumulation in Brain May Be an Early Sign of Parkinson’s

A team of researchers including Drs. Ole Isacson and Penny Hallett has found that elevated levels of certain types of fat molecules in the brain may be an early sign of Parkinson’s disease.

Researchers Find That Lipid Accumulation in the Brain May Be an Early Sign of Parkinson’s Disease

A collaborative team of researchers at McLean Hospital, a Harvard Medical School affiliate, and the University of Oxford has found that elevated levels of certain types of lipids (fat molecules) in the brain may be an early sign of Parkinson’s disease (PD). This finding could have significant...

Penny Hallett, PhD

Penny Hallett, PhD, is an associate professor of psychiatry at Harvard Medical School and co-director of the Neuroregeneration Research Institute (NRI). She received her PhD from the University of Manchester, UK, and completed post-doctoral studies at Massachusetts General Hospital, moving in 2006...

Penny Hallett Related Content

Type of Content

Video: Lecture – Autologous iPSC-Based Cell Therapy for Parkinson’s Disease

McLean Hospital Receives Coveted NIH Grant to Clinically Study Autologous Stem Cell Therapy for Parkinson’s Disease

In the Media: Elevated Lipid Levels May Be Early Biomarker for Parkinson’s, Study Suggests

In the Media: Researchers Find that Lipid Accumulation in Brain May Be an Early Sign of Parkinson’s

Researchers Find That Lipid Accumulation in the Brain May Be an Early Sign of Parkinson’s Disease

Penny Hallett, PhD

You May Also Like

Love Your Life Through the Science of Happiness

Introducing McLean SouthEast at Oak Street

McLean Hospital Opens Three New Inpatient Programs in Southeastern Massachusetts

Keep Up With McLean

Follow Us